- Reliq Health Technologies (TSXV:RHT) has expanded its services to include remote monitoring for pediatric patients with diabetes and other conditions
- The healthcare technology company expects to add more than 3,000 pediatric patients in Texas to its iUGO Care platform by Q2 2024 through its existing contracts with home health agencies in the state
- Pediatric patients in particular have better health outcomes and report better quality of life when they are able to receive care in the home
- Reliq Health Technologies Inc. stock opened trading at $0.45 per share
Reliq Health Technologies (TSXV:RHT) has expanded its services to include remote monitoring for pediatric patients with diabetes and other conditions.
The healthcare technology company expects to add more than 3,000 pediatric patients in Texas to its iUGO Care platform by Q2 2024 through its existing contracts with home health agencies in the state.
Reliq Health’s CEO, Dr. Lisa Crossley, explained in a news release that in Texas, Medicaid covers home telemonitoring (remote patient monitoring) for children with diabetes, hypertension, end-stage solid organ disease, organ transplant or who require mechanical ventilation.
“These vulnerable young patients can benefit greatly from in-home monitoring of their chronic conditions to identify potential complications, enable early interventions and prevent hospitalizations,” Crossley said in a statement. “Pediatric patients in particular have better health outcomes and report better quality of life when they are able to receive care in the home, surrounded by family and friends. Providing proactive support to pediatric patients through in-home monitoring can have a dramatic impact on patients’ long-term health, helping to prevent nerve damage, cardiovascular disease, organ damage and other complications that can lead to shortened lifespans and poor quality of life in adulthood. We expect to add over 3,000 pediatric patients to our iUGO Care platform by Q2 2024 through our existing contracts with home health agencies in the state, at an average revenue of $50 per patient per month at around 70 per cent gross margin. Onboarding will begin next month.”
See our recent profile on the company for a deeper look into the company and its iUGO platform.
Reliq Health Technologies develops virtual care solutions to allow complex patients to receive high-quality care at home, improve health outcomes, and reduce the cost of care.
Reliq Health Technologies stock opened trading at $0.45 per share.
Join the discussion: Find out what everybody’s saying about this stock on the Reliq Health Technologies Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.